The 2010s was a ground-breaking decade for the life science industry with the Food & Drug Administration approving a large number of innovative new therapies. Along with the increase in drug approvals over time was a steady decrease in the number of patients studied for each approval. Here is a visualization of every New Molecular Entity approved, grouped by ATC classification with larger circles representing a greater number of patients included in the clinical trial(s) supporting approval.
Hover over any circle to see more details. Additional details and all code used to obtain, clean and visualize the data are available here.
heading
company